Large Cap · Healthcare · Healthcare Plans
Large Cap · Healthcare · Healthcare Plans
Get the AI take on CI
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
70/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Current price
$278.5
Lowest
$290
Median target
$343
Highest
$400
Forward P/E
Favorable · 53% below avg
8.91x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.26x
Price / FCF
Strong · Priced well within what its cash flow supports
8.19x
EV / EBITDA
Strong · Operating earnings comfortably support this price
7.78x
ROIC
Reasonable · A middling return on the capital it puts to work
13.4%
ROE
Middle ground · Mixed
16.8%
Debt / equity
Favorable · 0.73 - solid leverage
0.74x
Current ratio
Weak · Not enough on hand to cover near-term bills
0.85x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $74.66B | 11.7 | +7.8% | 70 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |